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Abstract
Purpose: To evaluate the effects of preconception care (PCC) consultations by change in lifestyle behaviors.
Setting and Intervention: Women in deprived neighborhoods of 14 Dutch municipalities were encouraged to visit a general
practitioner or midwife for PCC.
Sample: The study included women aged 18 to 41 years who had a PCC consultation.
Design: In this community-based prospective cohort study, we assessed initiation of folic acid supplementation, cessation of
smoking, alcohol consumption, and illicit drug use.
Measures: Self-reported and biomarker data on behavioral changes were obtained at baseline and 3 months later.
Analysis: The changes in prevalence were assessed with the McNemar test.
Results:Of the 259 included participants, paired analyses were available in 177 participants for self-reported outcomes and in 82
for biomarker outcomes. Baseline self-reported prevalence of no folic acid use was 36%, smoking 12%, weekly alcohol use 22%,
and binge drinking 17%. Significant changes in prevalence toward better lifestyle during follow-up were seen for folic acid use (both
self-reported, P < .001; and biomarker-confirmed, P ¼ .008) and for self-reported binge drinking (P ¼ .007).
Conclusion: Our study suggests that PCC contributes to initiation of folic acid supplementation and cessation of binge drinking
in women who intend to become pregnant. Although based on a small sample, the study adds to the limited body of evidence
regarding the benefits of PCC in improving periconception health.
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Purpose
Preconception care (PCC) aims to prevent biomedical, beha-
vioral, and social risks from adversely affecting pregnancy by
reducing these risks before conception.1 For instance, lifestyle
behaviors such as smoking and alcohol consumption as well as
inadequate folic acid intake are associated with suboptimal
embryonic development.2-4 Unfortunately, such behavior is
widely prevalent among women in the preconception and early
pregnancy periods.5-8 Prevalence of inadequate folic acid is
around 39%, smoking 23%, and alcohol use 46%, based on a
National Online Self-Reported Risk Assessment.6
Preconception behavior interventions have focused on folic
acid, smoking, and alcohol before with varying effectiveness,
but little is known about actual behavior changes after a com-
prehensive PCC intervention in a general population of women
planning pregnancy.9-12
In 2011, the Healthy Pregnancy 4 All program was launched
to improve perinatal health and reduce related inequalities in
the Netherlands.13 Women were encouraged to visit a general
practitioner (GP) or midwife for PCC.14,15 The main objective
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of this study is to evaluate the effects of the program’s PCC
consultations on lifestyle behaviors.
Methods
Design
A prospective cohort was designed to study the effect of the
PCC consultations.14 The PCC consultations were planned as 2
individual visits with an interval of 3 months. During the first
visit, risk assessment was performed using a web-based ques-
tionnaire (including the domains lifestyle, medical, reproduc-
tive, and family history) and advice was provided according to
the national guideline.6,16 During the second visit, the identi-
fied risk factors and formulated plan were evaluated.
The primary outcome of the study was lifestyle behavior
change assessed as 4 independent outcomes: initiation of folic
acid supplementation, smoking cessation, reduction or cessa-
tion of alcohol consumption, and cessation of illicit drug use. In
addition, subgroup differences were explored.
The study was conducted in 14 municipalities selected based
on their relatively high perinatalmorbidity andmortality rates.13
A local outreach strategy for PCC was rolled out to promote
uptake. This strategy consisted of invitation letters sent by
municipal health services and GPs (including translations in 8
languages), as well as referral by youth health care professionals
and health educators.15 Preconception care was offered at parti-
cipating GPs and midwifery practices. The GPs and midwives
received a training aswell as self-studymaterial and protocols.14
Sample
Women aged 18 to 41 years who made an appointment for a
PCC consultation between February 2013 and December 2014
were eligible to participate in the study. In total, 587 PCC
appointments were registered and 259 (44%) participants were
included in the study after written informed consent.15 Partici-
pant enrolment is described in detail elsewhere.15
Measures
We collected baseline and follow-up measurements from ques-
tionnaires and blood samples. We dichotomized the outcomes
and used the following definitions of preconception risk
factors:
 No folic acid supplementation: self-reported “no” to folic
acid use, <20 nmol/L serum folate, and <590 nmol/L
erythrocyte folate.17,18
 Smoking: self-reported “current smoking” and cotinine
levels of >25 mg/L (reference value used by the
laboratory).19
 Alcohol consumption: self-reported drinking of “1 unit
(glass) or more per week” and self-reported binge
drinking of “>6 units per day in past 3 months,”
carbohydrate-deficient transferrin (CDT) above the
laboratory reference value of 2.2%, and one of the
homologues of PEth above the lower limit of quantifica-
tion of the laboratory, which was >6 mg/L for POPEth
and PLPEth, and >3 mg/L for DOPEth.20
 Illicit substance use: self-reported “current use” or “use
within the previous week.”15
Analysis
Weused descriptive statistics to show baseline characteristics of
the participants. Within the total sample of women with follow-
up data, we first testedwhether there was20% increase in self-
reported folic acid intake and 5% decrease in self-reported
smoking using the exact binomial test with a 1-sided signifi-
cance level of .025, as specified in the published protocol.14
An estimated sample size of 839 was calculated for the outcome
folic acid intake and 687 for smoking cessation. In addition, all
outcomes were analyzed paired for change between their pre-
valence at baseline and follow-up with the McNemar test.
Subgroup data are provided (Supplementary table) on the
self-reported outcomes. Subgroups were based on baseline
patient characteristics, self-reported pregnancy since PCC, and
women who filled in the baseline questionnaire before the PCC
consultation or later.
Table 1. Prevalence of Preconception Risk Factors at Baseline (T1)
and Follow-Up (T2).
Risk factors
All
casesa
Complete
casesb
P
valueT1% T1% T2%
No folic acid supplementation
Self-reported 35.6 33.5 20.6 .000c
Biomarker: Erythrocyte folate
<590 nmol/L
11.5d 7.6 4.5e .727
Biomarker: Serum folate <20 nmol/L 30.2 34.2 19.0 .008c
Smoking
Self-reported 12.9 11.7 14.6 .125
Biomarker: Cotinine 25 mg/L 12.1 11.2 11.2 1.000
Alcohol
Self-reported 1 U/wk 22.2 25.6 22.6 .359
Self-reported binge drinking >6 U/d 17.4 17.6 9.4 .007c
Biomarker: CDT >2.2% 0 0 0 NA
Biomarker: Homologue of PEth >
LLOQf
20.2 21.6 14.9d .180
Illicit substance use
Self-reported 2.6 2.4 0.6 .250
Abbreviations: BMI, body mass index; CDT, carbohydrate-deficient transferrin;
LLOQ, lower limit of quantification; NA, not applicable.
aBaseline cases (T1) self-reported outcomes N ¼ 237, biomarker outcomes
N ¼ 186.
bComplete cases self-reported outcomes N ¼ 177, biomarker outcomes N ¼
82. Median days between T1 and T2 self-reported outcomes 79, biomarker
outcomes 104.
cSignificant difference between paired groups, P < .05.
dMissing data between 5% and 10%.
eMissing data 19.5%.
fLower limit of quantification of POPEth and PLPEth >6 mg/L and of DOPEth
>3 mg/L.
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We used SPSS software for Windows, version 21, and sta-
tistical significance was accepted at .05 unless stated otherwise.
Results
Of the 259 participants, we collected 237 (92%) questionnaires
and 186 (72%) blood samples at baseline. Follow-up data con-
sisted of 177 (75%) questionnaires and 82 (44%) blood sam-
ples. The baseline characteristics of the 177 participants with
both questionnaires demonstrate that the median age was
30 years; 68.8% reported Dutch ethnical background; educa-
tional attainment was 7.5% low, 33.9% intermediate, and
55.7% high (International Standard Classification of Educa-
tion); 76.9% indicated a pregnancy intention within 6 months;
27.7% had been pregnant before; and 7.4% reported current or
previous fertility treatment. Comparing complete cases with
incomplete cases shows only more lost to follow-up among
non-Dutch participants (46.6% Dutch vs the earlier mentioned
68.8%; Supplementary table). Considering the risk factors no
folic acid supplementation, smoking, and alcohol consumption,
15.8% had no risk factor, 55.6% had 1 risk factors, 25.7% had 2
risk factors, and 2.9% had 3 risk factors.
Table 1 shows the primary outcomes. A significant increase
in self-reported and biomarker (serum folate) established folic
acid use was observed in the follow-up data, when compared to
baseline use. In addition, 42.1% (24/57) of women who
reported not taking folic acid at baseline had started taking
folic acid at the follow-up measurement (binomial test
20%, P < .001). The percentages of smoking showed no
change between baseline and follow-up, nor with the binomial
test  5% (P ¼ .736). Prevalence of reported binge drinking
decreased significantly. Only a few participants reported illicit
substance use at baseline and this showed no significant
decrease at follow-up.
Exploratory analyses indicated that the prevalenceof not using
folic acid supplementation, smoking, and alcohol consumption
varied across subgroups (Table 2). Possible associations with
subgroups were inconsistent for the 3 risk factors analyzed.
Discussion
Summary
This study has demonstrated that both self-reported and
biomarker-confirmed folic acid supplementation increased at
Table 2. Subgroup Analyses of Complete Cases for Self-Reported Data on No Folic Acid Supplementation, Smoking, and Alcohol Use.
Subgroups of complete casesa
Percent of no folic acid
supplementation Percent of smoking
Percent of alcohol use
1 U/wk
T1 T2 T1 T2 T1 T2
Total 33.5 20.6 11.7 14.6 25.6 22.6
Age (years)b
<25 47.1 29.4 27.8 38.9 17.6 17.6
25 31.1 18.5 9.9 11.9 26.8 23.5
Ethnicityb
Dutch 26.7 11.1 11.2 13.8 33.0 28.7
Other 46.0 32.0 13.7 17.6 10.2 10.2
Educationb
Low-intermediate 35.3 25.0 19.1 22.1 16.7 16.7
High 30.5 16.8 5.2 9.4 33.7 27.4
Pregnancy intention (months)b
<6 23.3 10.1 10.0 13.1 26.4 20.9
>6 70.6 64.7 17.1 20.0 21.2 30.3
Subfertilityb
Yes 38.5 15.4 0 7.7 0 0
No 32.3 20.6 12.2 14.7 27.9 24.7
Previous pregnancy
Yes 42.6 25.5 17.0 19.1 14.9 17.0
No 30.1 18.7 9.7 12.9 29.8 24.8
Pregnant since PCCc
Yes 25.0 8.3 2.8 5.6 25.7 20.0
No 35.8 23.9 14.1 17.0 25.6 23.3
Questionnaire timing
Prior to PCC 32.8 14.9 9.0 11.9 27.7 18.5
After PCC 34.0 24.3 13.5 16.3 24.3 25.2
Abbreviation: PCC, preconception care.
aComplete cases: N ¼ 177.
bMissing data 5% to 10% instead of below <5%.
c“Pregnant since PCC” is derived from follow-up data.
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follow-up after PCC. Furthermore, self-reported binge drinking
decreased. Our outcomes are largely in accordance with the
few other studies involving multifactorial preconception health
promotion interventions in a general population of women
planning to become pregnant. Previous studies often showed
a positive effect on initiation of folic acid and reducing alcohol
consumption, but less effect on cessation of smoking.17,21-24
Changing an addiction such as smoking will require more effort
than a single consultation.
The biomarker data mostly confirmed our results based on
self-reported data. Nevertheless, using higher erythrocyte
folate cutoff levels (900-1000 nmol/L) would probably have
been more appropriate and given the same results as the other 2
folic acid outcomes.25 There were no positive CDT levels,
indicating no severe alcohol consumption. PEth is known to
be better in retrospective monitoring (2-4 weeks) of moderate
alcohol consumption.20 PEth results suggest a reduction in pos-
itive cases in the period after PCC in line with less self-reported
binge drinking.
Targeting high-risk neighborhoods, it was expected that
the recruited study population would have higher baseline
prevalences of behavioral risks. However, the prevalences
we found were lower or similar to other cohorts. This might
be explained by the fact that most women were actively pre-
paring for pregnancy.6-8 It could also be that we did not suffi-
ciently reach high-risk women, since even though we did
reach a diverse population, the majority had a Dutch and high
educational background.15 Our exploratory findings on sub-
group differences are also reported by other studies; charac-
teristics such as younger age, ethnic minority background,
lower educational attainment, and a previous pregnancy seem
to be associated with no use of folic acid supplementation and
with smoking.6-9,18,26,27
Strengths and Limitations
Strengths of the study are the real-time community-based
approach and the assessment of biomarkers. Limitations
include the smaller sample size than intended,15 loss to
follow-up, and the possibility of a Hawthorne effect, in which
participation in a study stimulates positive outcomes.28 In addi-
tion, variation in timing of questionnaire responses, potential
differences in how the PCC consultations were delivered, and
variation in pregnancy intentions provide challenges in asses-
sing the actual effect of PCC.
Significance
Our study is one the few studies looking at actual preconcep-
tion lifestyle behavioral change. The results suggest that a
comprehensive PCC intervention has beneficial effects on
initiation of folic acid supplementation and cessation of binge
drinking in women who intend to become pregnant. Altogether,
the need and potential for PCC have been illustrated, but chal-
lenges remain with regard to targeting high-risk women and
attaining more improvement of health behaviors.
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